GBA Group Pharma: LKF focuses on SARS-CoV-2 analysis: Ongoing COVID-19 testing to maintain clinical studies

Written by Petra Hegmann on 19th May 2020. Posted in Client News.

[image_slider_no_space on_click=”prettyphoto” height=”600″ navigation_style=”light” images=”940,950,954,952,953,951″]